Stephanie Reid

Stephanie Reid supports the Centers for Disease Control and Prevention’s Office of Acquisition Services in managing mission-critical procurement activities that enable public health preparedness and scientific response. She oversees the acquisition of specialized laboratory equipment, diagnostic technologies, and research services critical to infectious disease surveillance, biomedical analysis, and epidemiological data operations. Her work directly supports CDC’s mandate to strengthen national laboratory capacity and ensure rapid deployment of analytical tools during public health emergencies, with a focus on high-compliance, technically complex procurements under FAR Part 15 and Part 36. Reid maintains strategic relationships with leading contractors including General Dynamics Information Technology, GlaxoSmithKline, MRIGLOBAL, and Cepheid, partnering with organizations that deliver advanced diagnostic platforms, biosafety-compliant laboratory systems, and large-scale public health research support. Her procurement approach emphasizes vendor reliability, technical expertise, and regulatory compliance, particularly in areas requiring FDA-cleared or CLIA-certified solutions. She frequently engages with contractors possessing deep domain knowledge in clinical diagnostics, biospecimen handling, and real-time pathogen detection systems. Her contracting portfolio reflects a strong preference for unrestricted competitions, with 96% of awards issued without set-asides, indicating a focus on technical merit and mission urgency over socioeconomic classifications. While small business participation remains limited at 4%, it is strategically directed toward total small business set-asides under FAR 19.5, prioritizing capability over socioeconomic status. Reid’s primary procurement focus lies in NAICS 334516 (analytical laboratory instrumentation) and 811210 (precision equipment maintenance), reflecting her specialization in high-end diagnostic hardware and its sustained operational support. She also frequently procures research and development services under NAICS 541715, partnering with entities capable of advancing molecular diagnostics, genomic sequencing, and data-driven public health modeling technologies.